Welcome To The Ondine Biopharma HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Ondine Announces Presentation of Positive Clinical Trial Results

Ondine Announces Presentation of Positive Clinical Trial Results

posted on Sep 05, 2008 05:05AM

Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontology's 94th Annual Meeting
Friday September 5, 7:30 am ET



VANCOUVER, Sept. 5 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM: OBP), a medical technology company developing photodisinfection-based products, today announced that a poster entitled "Photodisinfection in the Treatment of Chronic Periodontitis" will be presented by Company representatives at the American Academy of Periodontology's (AAP) annual meeting. This year's AAP meeting is being held at the Washington State Convention and Trade Center in Seattle, Washington on September 6-9, 2008.

"We are pleased to have the opportunity to present photodisinfection to the U.S. periodontal community," said Carolyn Cross, Ondine's President and CEO. "This peer-reviewed poster highlights the positive results of the Company's Multi-Centre Trial using its Photodisinfection System. Periodontal pockets treated with photodisinfection (220mW laser plus photosensitizer) in addition to scaling and root planing (SRP) yielded statistically significant reductions in pocket depth (p=0.01) as well as increases in clinical attachment level (p=0.002) when compared to pockets treated only with SRP."

Share
New Message
Please login to post a reply